Evidence map›Paper›PMID 40624411›Full record

ArticleEJNMMI physics2025

Evaluation of using small volume of interest regions for clinical kidney dosimetry in

Jehangir Khan, Tobias Rydèn, Martijn Van Essen, Johanna Svensson, Peter Bernhardt

Abstract read
In one paragraph

Article in EJNMMI physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jehangir KhanDepartment of Medical Physics and Biomedical Engineering (MFT), Sahlgrenska University Hospital, Gothenburg, SE-41345, Sweden. Jehangir.khan@gu.se.ORCID http://orcid.org/0000-0002-9146-6396
Tobias RydènDepartment of Medical Physics and Biomedical Engineering (MFT), Sahlgrenska University Hospital, Gothenburg, SE-41345, Sweden.
Martijn Van EssenDepartment of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Johanna SvenssonDepartment of Oncology, Institution of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Peter BernhardtDepartment of Medical Physics and Biomedical Engineering (MFT), Sahlgrenska University Hospital, Gothenburg, SE-41345, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Segmentation of the whole-kidney parenchyma (WKP) is considered the reference method for kidney dosimetry of radiopharmaceuticals, as it provides the average absorbed dose to the fully delineated WKP. However manual segmentation of the WKP is time consuming, and automated segmentation requires operator verification and potential manual adjustments to the VOI. The aim is to determine if a small volume of interest (SV) method can generate similar kidney absorbed doses as the WKP method.

methodsWe obtained SPECT/CT of 18 patients at 24, 48, and 168 h after injection of [

resultsThe mean RCs of the WKP volumes (31-243 mL) in non-filtered ASCC-SPECT and AC-SPECT were 0.85 (0.73-0.90) and 0.62 (0.46-0.51), respectively. In non-filtered images, the absorbed dose was overestimated by a factor of 1.22. However, applying a Gaussian filter with a kernel size of approximately 5 mm yielded absorbed dose estimates comparable to the reference WKP method. The accuracy of kidney dosimetry calculation based on one SV

conclusionThe small volume of interest (SV) method can provide absorbed dose estimates comparable to the whole-kidney parenchyma (WKP) method when optimized. Non-filtered images overestimated doses by 1.22, but applying a 5 mm Gaussian filter aligned SV results with the WKP method. Using multiple VOIs improved accuracy, with five 2 mL SVs achieving 8.3%. The SV method provides a less time-consuming alternative to WKP; however, its implementation is recommended to be validated and adjusted against a reference method.

Indexed as

177Lu-DOTATATEKidney dosimetryNeuroendocrineRecovery coefficientSingle-photon emission tomographySPECT/CT

Identifiers

PMID40624411
PMCPMC12234931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.